INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th

Go back to INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th
(NASDAQ: INMB) Delayed: 2.44 +0.17 (7.49%)
Previous Close $2.27    52 Week High
Open $2.27    52 Week Low
Day High $2.45    P/E N/A 
Day Low $2.22    EPS
Volume 323,962       

(NASDAQ: INMB) Delayed: 2.44 +0.17 (7.49%)
Previous Close $2.27    52 Week High
Open $2.27    52 Week Low
Day High $2.45    P/E N/A 
Day Low $2.22    EPS
Volume 323,962